mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.07 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.059 |
0.07 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.07 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.08 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.08 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.08 |